解读乳房植入物疾病:病因是关键
乳房植入物疾病(BII)自1962年FDA批准植入物以来一直是争议性并发症,主流媒体和社交媒体上的非科学讨论持续影响患者决策。本文综述了BII病因的多种假说,指出目前缺乏科学研究和最终结论,旨在启发改善BII患者状况的思路。
要点
- BII病因、临床表现、诊断标准及治疗均无最终结论。
- 主流媒体和社交媒体的非科学讨论影响患者决策。
- 综述BII病因假说以启发改善患者状况。
核心结论
- BII仍是一个定义不清且有争议的并发症,揭示其病因紧迫且影响患者决策。
研究设计与样本
- 综述,旨在概述BII病因的假说并寻求改善BII患者状况的启发。
主要发现
- 目前关于BII的科学数据极少或缺乏,尚无关于其病因、临床表现、诊断标准或治疗的最终结论。
局限性
- 目前关于BII的科学数据极少或缺乏,尚无最终结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Because breast augmentation is one of the most popular cosmetic procedures, the issue of implant-related complications has been widely debated ever since the FDA approved the use of implants in 1962. Although decades have passed, breast implant illness (BII) still represents a poorly defined and controversial complication. With ongoing nonscientific discussion in the mainstream media and on social media, revealing the etiology of BII is urgent because knowledge of this subject ultimately influences patients' decisions. Little or no scientific research is currently available on BII and no final conclusions regarding its etiology, clinical manifestations, diagnostic criteria, or treatment have been made. This review aims to give an overview of the hypotheses on the etiology of BII and seeks inspiration to improve the conditions of BII patients.
引用
- Yang S, Klietz ML, Harren AK, et al. Understanding Breast Implant Illness: Etiology is the Key. Aesthet Surg J. 2022. PMID: 33871569. doi:10.1093/asj/sjab197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。